Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Tetraphase Pharmaceuticals patents

List of Tetraphase Pharmaceuticals patents

List of Voxtel Inc. patents

List of Qpex Biopharma patents

List of ZyXEL patents

List of companies in Hunter Walk's investment portfolio

CEOs of shoe companies

Patents where

Current Assignee

Name

is

Tetraphase Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11578044 Crystalline forms of eravacycline		Tetraphase Pharmaceuticals	Tetraphase Pharmaceuticals		United States Patent and Trademark Office	11578044	February 14, 2023
	‌ US Patent 10913712 Tetracycline compounds	Patent 10913712 was granted and assigned to Tetraphase Pharmaceuticals on February, 2021 by the United States Patent and Trademark Office.	Tetraphase Pharmaceuticals	Tetraphase Pharmaceuticals		United States Patent and Trademark Office	10913712	February 9, 2021
	‌ US Patent 9315451 Tetracycline compounds	Patent 9315451 was granted and assigned to Tetraphase Pharmaceuticals on April, 2016 by the United States Patent and Trademark Office.		Tetraphase Pharmaceuticals		United States Patent and Trademark Office	9315451	April 19, 2016
	‌ US Patent 9371283 Polycyclic tetracycline compounds	Patent 9371283 was granted and assigned to Tetraphase Pharmaceuticals on June, 2016 by the United States Patent and Trademark Office.		Tetraphase Pharmaceuticals		United States Patent and Trademark Office	9371283	June 21, 2016
	‌ US Patent 9624166 Tetracycline compounds	Patent 9624166 was granted and assigned to Tetraphase Pharmaceuticals on April, 2017 by the United States Patent and Trademark Office.		Tetraphase Pharmaceuticals		United States Patent and Trademark Office	9624166	April 18, 2017
	‌ US Patent 10315992 Tetracyline compounds	Patent 10315992 was granted and assigned to Tetraphase Pharmaceuticals on June, 2019 by the United States Patent and Trademark Office.	Tetraphase Pharmaceuticals	Tetraphase Pharmaceuticals		United States Patent and Trademark Office	10315992	June 11, 2019
	‌ US Patent 10961190 Crystalline forms of eravacycline	Patent 10961190 was granted and assigned to Tetraphase Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.	Tetraphase Pharmaceuticals	Tetraphase Pharmaceuticals		United States Patent and Trademark Office	10961190	March 30, 2021
	‌ US Patent 10072007 Tetracycline compounds	Patent 10072007 was granted and assigned to Tetraphase Pharmaceuticals on September, 2018 by the United States Patent and Trademark Office.	Tetraphase Pharmaceuticals	Tetraphase Pharmaceuticals		United States Patent and Trademark Office	10072007	September 11, 2018
	‌ US Patent 10618879 Semi-synthesis procedures		Tetraphase Pharmaceuticals	Tetraphase Pharmaceuticals		United States Patent and Trademark Office	10618879	April 14, 2020
	‌ US Patent 9573895 Tetracycline compounds	Patent 9573895 was granted and assigned to Tetraphase Pharmaceuticals on February, 2017 by the United States Patent and Trademark Office.	Tetraphase Pharmaceuticals	Tetraphase Pharmaceuticals		United States Patent and Trademark Office	9573895	February 21, 2017
	‌ US Patent 8906887 C7-fluoro substituted tetracycline compounds	Patent 8906887 was granted and assigned to Tetraphase Pharmaceuticals on December, 2014 by the United States Patent and Trademark Office.		Tetraphase Pharmaceuticals		United States Patent and Trademark Office	8906887	December 9, 2014
	‌ US Patent 8796245 C7-fluoro substituted tetracycline compounds	Patent 8796245 was granted and assigned to Tetraphase Pharmaceuticals on August, 2014 by the United States Patent and Trademark Office.		Tetraphase Pharmaceuticals		United States Patent and Trademark Office	8796245	August 5, 2014
	‌ US Patent 10087157 Semi-synthesis procedures	Patent 10087157 was granted and assigned to Tetraphase Pharmaceuticals on October, 2018 by the United States Patent and Trademark Office.	Tetraphase Pharmaceuticals	Tetraphase Pharmaceuticals		United States Patent and Trademark Office	10087157	October 2, 2018
	‌ US Patent 8367654 8-AZA tetracycline compounds	Patent 8367654 was granted and assigned to Tetraphase Pharmaceuticals on February, 2013 by the United States Patent and Trademark Office.		Tetraphase Pharmaceuticals		United States Patent and Trademark Office	8367654	February 5, 2013
	‌ US Patent 8828988 8-AZA tetracycline compounds			Tetraphase Pharmaceuticals		United States Patent and Trademark Office	8828988	September 9, 2014
	‌ US Patent 8501716 C7-fluoro substituted tetracycline compounds	Patent 8501716 was granted and assigned to Tetraphase Pharmaceuticals on August, 2013 by the United States Patent and Trademark Office.		Tetraphase Pharmaceuticals		United States Patent and Trademark Office	8501716	August 6, 2013

16 results

0 selected

16 results

0 selected